Mesothelioma News
Mesothelioma and the Spread of Asbestos |
Mesothelioma, Asbestos, and Survival |
Mesothelioma and Active Symptom Control |
Mesothelioma and Children |
Mesothelioma and Chemo Results |
Mesothelioma and the Immune System |
Mesothelioma Survivor Speaks |
Peritoneal Mesothelioma and Multi-Modality Treatment |
Mesothelioma and Chemotherapy |
Pleural Mesothelioma and Surgery |
Mesothelioma and Molecular Pathways |
Mesothelioma and Virotherapy |
Asbestos a Deadly Carcinogen |
Anti-Asbestos Crusader, Dr. Irving Selikoff |
Mesothelioma and Gene Expression |

Widespread Health Concerns Linger After Asbestos-Contaminated Mine Closes
Study Suggests that Greater Asbestos Exposure Shortens Mesothelioma Survival
Adding Chemotherapy Does Little to Improve Survival or Quality of Life in Mesothelioma Patients
Mesothelioma Rare, Difficult to Diagnose in Children
Second Round of Chemotherapy Treatment Promising for Mesothelioma Patients
New study examines immune cells impact on mesothelioma survival
10-Year Mesothelioma Survivor Paul Kraus Gave Another Inspiring Talk to Mesothelioma Patients
Combination Treatment for Peritoneal Mesothelioma Dramatically Boosts Survival
Additional Chemotherapy Treatment Slows Pleural Mesothelioma Progression According to Study
David J. Sugarbaker, MD discusses the pros and cons of surgery for mesothelioma
Molecular signaling pathways may provide clues to targeted therapies for mesothelioma
Virotherapy - a Potential Therapy in Treating Mesothelioma
Dr. Irving Selikoff was one of the first scientists to change the way the world viewed and treated asbestos
Connection between malignant mesothelioma and the overexpression of a genetic protein